THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES

Registered charity 1143472 · accounts filings on the Charity Commission register · also known as MPS SOCIETY, WICKED GENES · also registered in Scotland as SC041012 (OSCR)

THIS IS THE INCORPORATED SUCCESSOR CHARITY TO CHARITY NUMBER 287034, WHICH IS ITS UNINCORPORATED PREDECESSOR.The MPS Society is the only registered UK charity providing professional support to individuals, families and professionals affected by MPS and related diseases throughout the UK.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Disability · website · Get email alerts

Latest income
£2.2m
Latest spending
£2.2m
Registered
2011
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a surplus of £59,648 for the year ended 31 December 2025, with total group income of £2,184,220 against total expenditure of £2,152,485. Per the trustees' report, free reserves amounted to £740,781, which exceeds the stated policy target of six months of unrestricted resources.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: six months of the unrestricted resources (held: £741k)
“the trustees agreed to the established policy whereby the unrestricted funds not committed or invested in tangible fixed assets (‘the free reserves’) held by the charity should be six months of the unrestricted resources.” — page 12
Per its FY2025 accounts as filed with the Charity Commission.
Trading subsidiary: MPS Commercial Limited, Rare Disease Research Partners Limited
“MPS Commercial Limited (trading as Rare Disease Research Partners) is a wholly owned trading subsidiary of the MPS Society.” — page 12
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Xeinadin Audit Limited. Discloses 4 of 6 completeness components.

Corporate structure

MPS COMMERCIAL LIMITED — per its own Companies House accounts
  • Profit before tax: £157k
  • Donated/gift-aided to the charity: £157k
  • Interest charged on intercompany loan: £6,375. Intercompany loan balance owed to parent: £256,680.
“The company distributes all of its profits to its parent undertaking, The Society For Mucopolysaccharide Diseases under Gift Aid. The payment for 2025 was £156,680”
RARE DISEASE RESEARCH PARTNERS LTD — per its own Companies House accounts
  • Donated/gift-aided to the charity: £1
  • Amounts owed by group undertakings were £1,000 in 2025 and £4,000 in 2024.
“Amounts owed by group undertakings 1 4”

Public fundraising profile: JustGiving — The Society For Mucopolysaccharide Diseases (The MPS Society) (matched by registered charity number).

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Company officers (Companies House)

Current officers of the charity’s own company per the Companies House register, cross-checked against the Charity Commission trustee list by name. A director not on the trustee list is usually a timing or naming difference between the two registers — check both records before drawing conclusions.

Official officers record.

Property (HM Land Registry)

2 registered titles in England and Wales held by the charity’s company or corporate body (2 freehold). All charity-held property. Contains HM Land Registry data © Crown copyright, OGL v3.0.

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2025)

Total income
£2.2m
Total spending
£2.2m
Cost of raising funds
£684k
Reserves (reported)
£750k
Employees
30

Reported reserves equal ~4.2 months of spending — below the median for charities its size (median 4.8 months; benchmarks).

Per its annual return, largest income source: Other trading activities (43% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 31.3% of total income — in the top quarter for charities its size (median 5.2%) (benchmarks).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£2.2m£2.2m
31/12/2024£1.9m£1.9m
31/12/2023£1.8m£2.0m
31/12/2022£1.7m£2.0m
31/12/2021£1.4m£1.6m

Common questions

Is THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a surplus of £59,648 for the year ended 31 December 2025, with total group income of £2,184,220 against total expenditure of £2,152,485. Per the trustees' report, free reserves amounted to £740,781, which exceeds the stated policy target of six months of unrestricted resources. Its FY2025 accounts were audited by Xeinadin Audit Limited.

Who funds THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES?

Funders whose own accounts filings name THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES as a grant recipient include THE JOHN COATES CHARITABLE TRUST, THE CLOVER TRUST, THE ADINT CHARITABLE TRUST, PILKINGTON CHARITIES FUND, SANDRA CHARITABLE TRUST.

Known funders

Grants to this charity found in funders’ own accounts filings.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
The National Lottery Community Fund25/07/2024£20kMental health support for people with MPS; Fabry and related diseases
The National Lottery Community Fund20/12/2023£418kRare But Not Alone
The National Lottery Community Fund13/05/2022£10kCounselling for young people diagnosed with an MPS or related disease
The National Lottery Community Fund03/03/2021£195kRare but not alone- Connecting the MPS Community
The National Lottery Community Fund11/05/2020£38kAdvocacy and support- Covid 19 response
City Bridge Foundation06/06/2013£77kGrant to Society for Mucopolysaccharide Diseases
The National Lottery Community Fund22/11/2005£4kTraining for volunteers

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with MULTIPLE SCLEROSIS SOCIETY.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES£2.2m——above—no doubt
MULTIPLE SCLEROSIS SOCIETY FY2024£29.8m——unclear—no doubt
THE CHRONIC GRANULOMATOUS DISORDER SOCIETY FY2025£359k—0within41.0%no doubt
THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND FY2024£1.5m—0above—no doubt
THE MACULAR DISEASE SOCIETY FY2025£8.9m——above—no doubt
The UK Myeloma Society FY2025£190k—0above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.